Actively engaging patients in treatment decision making and monitoring as a strategy to improve hypertension outcomes in diabetes mellitus

Circulation

Volumn 117, Issue 11, 2008, Pages 1355-1357

  Heisler, Michele ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Communication; Editorials; Hypertension; Patients

Indexed keywords

BLOOD PRESSURE REGULATION; COST EFFECTIVENESS ANALYSIS; DECISION MAKING; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DOCTOR PATIENT RELATION; EDITORIAL; HYPERTENSION; PATIENT COMPLIANCE; PATIENT MONITORING; PATIENT PARTICIPATION; PRIORITY JOURNAL; RISK REDUCTION; SELF CARE; SOCIOECONOMICS; TREATMENT OUTCOME; TREATMENT PLANNING; ATTITUDE TO HEALTH; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; COOPERATION; DISEASE MANAGEMENT; HEALTH PERSONNEL ATTITUDE; HUMAN; MOTIVATION; NOTE; PATIENT EDUCATION; PSYCHOLOGICAL ASPECT;

ATTITUDE OF HEALTH PERSONNEL; ATTITUDE TO HEALTH; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; COOPERATIVE BEHAVIOR; DECISION MAKING; DIABETES COMPLICATIONS; DISEASE MANAGEMENT; GOALS; HUMANS; HYPERTENSION; PATIENT EDUCATION AS TOPIC; PHYSICIAN-PATIENT RELATIONS;

EID: 41649098544     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.108.764514     Document Type: Editorial

References (19)

1. Grundy SM, Howard B, Smith S Jr, Eckel R, Redberg R, Bonow RO. Prevention Conference VI: Diabetes and Cardiovascular Disease: executive summary: conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation. 2002;105:2231-2239.
2. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
3. CDC Diabetes Cost-Effectiveness Group. Cost-effectiveness of intensive glycemic control, intensified hypertension control, and serum cholesterol level reduction for type 2 diabetes. JAMA. 2002;287:2542-2551.
4. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green AL, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, for the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure, National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA. 2003;289:2560-2572.
5. Saydah SH, Fradkin J, Cowie CC. Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA. 2004;291:335-342.
6. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM. A diabetes report card for the United States: quality of care in the 1990s. Ann Intern Med. 2002;136:565-574.
7. Glasgow RE, Anderson RM. In diabetes care, moving from compliance to adherence is not enough: something entirely different is needed. Diabetes Care. 1999;22:2090-2092. Letter.
8. World Health Organization. Adherence to long-term therapies: evidence for action. Available at: www.who.int/chronic_conditions/adherencereport/en. Accessed January 26, 2008.
9. Osterberg L, Blaschke T. Adherence to medication. N Engl J Med. 2005;353:487-497.
10. Phillips LS, Branch WT, Cook CB, Doyle JP, El-Kebbi IM, Gallina DL, Miller CD, Ziemer DC, Barnes CS. Clinical inertia. Ann Intern Med. 2001;135:825-834.
11. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218-1224.
12. DiMatteo MR. Variations in patients' adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42:200-209.
13. Stephenson J. Noncompliance may cause half of antihypertensive drug "failures." JAMA. 1999;282:313-314.
14. Grant RW, Buse JB, Meigs JB. Quality of diabetes care in US academic medical centers: low rates of medical regimen change. Diabetes Care. 2005;28:337-442.
15. Marvel MK, Epstein RM, Flowers K, Beckman HB. Soliciting the patient's agenda: have we improved? JAMA. 1999;281:283-287.
16. DiMatteo MR, Sherbourne CD, Hays RD, Ordway L, Kravitz RL, McGlynn EA, Kaplan S, Rogers WH. Physicians' characteristics influence patients' adherence to medical treatment: results from the Medical Outcomes Study. Health Psychol. 1993;12:93-102.
17. Heisler M, Vijan S, Anderson RM, Ubel PA, Bernstein SJ, Hofer TP. When do patients and their physicians agree on diabetes treatment goals and strategies, and what difference does it make? J Gen Intern Med. 2003;18:893-902.
18. Naik AD, Kallen MA, Walder A, Street RL. Improving hypertension control in diabetes mellitus: the effects of collaborative and proactive health communication. Circulation. 2008;117:1361-1368.
19. Cappuccio FP, Kerry SM, Forbes L, Donald A. Blood pressure control by home monitoring: meta-analysis of randomized trials. BMJ. 2004;329:145-151.